These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 1705010)
1. Identification of domains of the v-crk oncogene product sufficient for association with phosphotyrosine-containing proteins. Matsuda M; Mayer BJ; Hanafusa H Mol Cell Biol; 1991 Mar; 11(3):1607-13. PubMed ID: 1705010 [TBL] [Abstract][Full Text] [Related]
2. Biological and biochemical activity of v-Crk chimeras containing the SH2/SH3 regions of phosphatidylinositol-specific phospholipase C-gamma and Src. Matsuda M; Reichman CT; Hanafusa H J Virol; 1992 Jan; 66(1):115-21. PubMed ID: 1370084 [TBL] [Abstract][Full Text] [Related]
3. Binding of transforming protein, P47gag-crk, to a broad range of phosphotyrosine-containing proteins. Matsuda M; Mayer BJ; Fukui Y; Hanafusa H Science; 1990 Jun; 248(4962):1537-9. PubMed ID: 1694307 [TBL] [Abstract][Full Text] [Related]
4. Direct binding of C-terminal region of p130Cas to SH2 and SH3 domains of Src kinase. Nakamoto T; Sakai R; Ozawa K; Yazaki Y; Hirai H J Biol Chem; 1996 Apr; 271(15):8959-65. PubMed ID: 8621540 [TBL] [Abstract][Full Text] [Related]
5. Tyrosine-phosphorylated epidermal growth factor receptor and cellular p130 provide high affinity binding substrates to analyze Crk-phosphotyrosine-dependent interactions in vitro. Birge RB; Fajardo JE; Mayer BJ; Hanafusa H J Biol Chem; 1992 May; 267(15):10588-95. PubMed ID: 1375224 [TBL] [Abstract][Full Text] [Related]
6. Activation of c-Src in cells bearing v-Crk and its suppression by Csk. Sabe H; Okada M; Nakagawa H; Hanafusa H Mol Cell Biol; 1992 Oct; 12(10):4706-13. PubMed ID: 1383688 [TBL] [Abstract][Full Text] [Related]
7. Possible v-Crk-induced transformation through activation of Src kinases. Sabe H; Shoelson SE; Hanafusa H J Biol Chem; 1995 Dec; 270(52):31219-24. PubMed ID: 8537387 [TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of a high-affinity interaction between v-Crk and tyrosine-phosphorylated paxillin in CT10-transformed fibroblasts. Birge RB; Fajardo JE; Reichman C; Shoelson SE; Songyang Z; Cantley LC; Hanafusa H Mol Cell Biol; 1993 Aug; 13(8):4648-56. PubMed ID: 7687742 [TBL] [Abstract][Full Text] [Related]
9. The SH2- and SH3-containing Nck protein transforms mammalian fibroblasts in the absence of elevated phosphotyrosine levels. Chou MM; Fajardo JE; Hanafusa H Mol Cell Biol; 1992 Dec; 12(12):5834-42. PubMed ID: 1280326 [TBL] [Abstract][Full Text] [Related]
10. A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner. Sakai R; Iwamatsu A; Hirano N; Ogawa S; Tanaka T; Mano H; Yazaki Y; Hirai H EMBO J; 1994 Aug; 13(16):3748-56. PubMed ID: 8070403 [TBL] [Abstract][Full Text] [Related]
11. Multiple SH2-mediated interactions in v-src-transformed cells. Koch CA; Moran MF; Anderson D; Liu XQ; Mbamalu G; Pawson T Mol Cell Biol; 1992 Mar; 12(3):1366-74. PubMed ID: 1545818 [TBL] [Abstract][Full Text] [Related]
12. Expression of the v-crk oncogene product in PC12 cells results in rapid differentiation by both nerve growth factor- and epidermal growth factor-dependent pathways. Hempstead BL; Birge RB; Fajardo JE; Glassman R; Mahadeo D; Kraemer R; Hanafusa H Mol Cell Biol; 1994 Mar; 14(3):1964-71. PubMed ID: 7509449 [TBL] [Abstract][Full Text] [Related]
14. A 31-amino-acid N-terminal extension regulates c-Crk binding to tyrosine-phosphorylated proteins. Fajardo JE; Birge RB; Hanafusa H Mol Cell Biol; 1993 Dec; 13(12):7295-302. PubMed ID: 7504172 [TBL] [Abstract][Full Text] [Related]
15. Mutagenic analysis of the v-crk oncogene: requirement for SH2 and SH3 domains and correlation between increased cellular phosphotyrosine and transformation. Mayer BJ; Hanafusa H J Virol; 1990 Aug; 64(8):3581-9. PubMed ID: 1695251 [TBL] [Abstract][Full Text] [Related]
16. Structural requirement of CRK SH2 region for binding to phosphotyrosine-containing proteins. Evidence from reactivity to monoclonal antibodies. Matsuda M; Nagata S; Tanaka S; Nagashima K; Kurata T J Biol Chem; 1993 Feb; 268(6):4441-6. PubMed ID: 7680038 [TBL] [Abstract][Full Text] [Related]
17. v-Crk activates the phosphoinositide 3-kinase/AKT pathway by utilizing focal adhesion kinase and H-Ras. Akagi T; Murata K; Shishido T; Hanafusa H Mol Cell Biol; 2002 Oct; 22(20):7015-23. PubMed ID: 12242282 [TBL] [Abstract][Full Text] [Related]
19. Src homology region 2 domains direct protein-protein interactions in signal transduction. Moran MF; Koch CA; Anderson D; Ellis C; England L; Martin GS; Pawson T Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8622-6. PubMed ID: 2236073 [TBL] [Abstract][Full Text] [Related]
20. Suppression of c-Src activity by C-terminal Src kinase involves the c-Src SH2 and SH3 domains: analysis with Saccharomyces cerevisiae. Murphy SM; Bergman M; Morgan DO Mol Cell Biol; 1993 Sep; 13(9):5290-300. PubMed ID: 7689149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]